DIFFERENCES IN QUALITY OF LIFE AMONG PATIENTS UNDERGOING REGULAR HEMODIALYSIS AND CONTINUOUS AMBULATORY PERITONEAL DIALYSIS AT NGOERAH GENERAL HOSPITAL

Abstrak

End-Stage Kidney Disease (ESKD) is characterized by the irreversible decline of renal function, necessitating continuous renal replacement therapy such as Hemodialysis (HD) or Continuous Ambulatory Peritoneal Dialysis (CAPD). HD utilizes a dialyzer apparatus in a clinical setting, whereas CAPD can be conducted independently by patients. Both modalities significantly influence patients' quality of life due to the potential adverse effects associated with each therapy, thereby rendering quality of life a critical parameter for assessing ESKD treatment outcomes across physical, psychological, social, and environmental dimensions. This cross-sectional investigation explores the disparities in quality of life between 25 patients undergoing HD and 25 patients receiving CAPD at Ngoerah General Hospital, using the EQ5D questionnaire as a measurement tool. The analysis carried out utilizing SPSS version 26 uncovered statistically significant variations in mobility (p=0.04), daily activities (p=0.003), pain/discomfort (p=0.006), and anxiety/depression (p=0.046) between patients undergoing HD and CAPD. In contrast, no significant difference was observed in self-care (p=0.65). The results indicate that patients utilizing CAPD experience a superior overall quality of life (p=0.007) compared to their HD counterparts. This investigation offers valuable insights for enhancing patient care and underpins informed decision-making regarding the selection of dialysis therapies